|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0021760,
umls-concept:C0162574,
umls-concept:C0205227,
umls-concept:C0205250,
umls-concept:C0205251,
umls-concept:C0229671,
umls-concept:C0332281,
umls-concept:C0597357,
umls-concept:C1327616,
umls-concept:C1704264
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-14
|
|
pubmed:abstractText |
Advanced glycation end products (AGEs) are thought to cause inflammation through interaction with the receptor for AGEs (RAGE), therefore contributing to adverse aging-related processes. The relationship between AGEs, RAGE, and inflammation has not been well characterized.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Lysine,
http://linkedlifedata.com/resource/pubmed/chemical/N(6)-carboxymethyllysine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/advanced glycosylation end-product...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1758-535X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
437-43
|
|
pubmed:meshHeading |
pubmed-meshheading:21357189-Adult,
pubmed-meshheading:21357189-Aged,
pubmed-meshheading:21357189-Aged, 80 and over,
pubmed-meshheading:21357189-Female,
pubmed-meshheading:21357189-Humans,
pubmed-meshheading:21357189-Inflammation,
pubmed-meshheading:21357189-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:21357189-Interleukin-18,
pubmed-meshheading:21357189-Interleukin-1beta,
pubmed-meshheading:21357189-Interleukin-6,
pubmed-meshheading:21357189-Italy,
pubmed-meshheading:21357189-Longitudinal Studies,
pubmed-meshheading:21357189-Lysine,
pubmed-meshheading:21357189-Male,
pubmed-meshheading:21357189-Middle Aged,
pubmed-meshheading:21357189-Receptors, Immunologic,
pubmed-meshheading:21357189-Receptors, Interleukin-6,
pubmed-meshheading:21357189-Transforming Growth Factor beta,
pubmed-meshheading:21357189-Tumor Necrosis Factor-alpha,
pubmed-meshheading:21357189-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Endogenous secretory receptor for advanced glycation end products is associated with low serum interleukin-1 receptor antagonist and elevated IL-6 in older community-dwelling adults.
|
|
pubmed:affiliation |
Department of Ophthalmology, Johns Hopkins University School of Medicine, Smith Building M015, 400 N. Broadway, Baltimore, MD 21287, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|
